IMAX (NYSE:IMAX) Hits New 1-Year High After Analyst Upgrade

IMAX Corporation (NYSE:IMAX) hit a new 52-week high during trading on Thursday after JPMorgan Chase & Co. raised their price target on the stock from $47.00 to $48.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. IMAX traded as high as $40.00 and last traded at $39.9350, with a volume of 213642 shares. The stock had previously closed at $36.52.

Several other equities analysts have also commented on the stock. Wall Street Zen raised shares of IMAX from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 7th. The Goldman Sachs Group raised shares of IMAX from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $22.00 to $34.00 in a research note on Tuesday, November 25th. B. Riley Financial restated a “buy” rating on shares of IMAX in a report on Monday, December 8th. Macquarie Infrastructure increased their target price on IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $47.00 target price on shares of IMAX in a report on Tuesday. Ten equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $43.00.

Key Stories Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Q4 earnings beat and strong growth — IMAX reported $0.58 EPS vs. $0.43 consensus and revenue of $125.2M (up ~35% y/y), driven by blockbuster titles and higher profitability. This is the primary catalyst for the stock move. Earnings Report
• Positive Sentiment: Analyst upgrades — JPMorgan raised its price target to $48 and kept an “overweight” rating, signaling meaningful upside; Benchmark also raised its target to $44 and reiterated a “buy”. Analyst bullishness supports further upside sentiment. Analyst Note Benchmark Note
• Positive Sentiment: Strong box-office backdrop and targets — Management outlined a $1.4B global box-office target for 2026 and is expanding premium content and network reach, suggesting recurring upside if tentpoles and slate perform. Box Office Target
• Positive Sentiment: Content wins and programming diversification — Dune 3 secured exclusive IMAX opening-weekend play in select markets (good for premium ticket sales), Studio Ghibli re-releases and live F1 broadcasts broaden non-traditional revenue streams. Dune 3 Article Ghibli Re-release F1 in IMAX
• Neutral Sentiment: Institutional support — Rosenblatt reiterated a buy and other boutiques remain constructive; this helps sentiment but is not new fundamental strength. Rosenblatt Note
• Neutral Sentiment: Investor materials available — The earnings call transcript and slide deck were published for deeper inspection; useful for gauging guidance and margin drivers but not an immediate price catalyst. Earnings Call Transcript
• Negative Sentiment: Opening-weekend windowing risk — Major title Avengers: Doomsday will not have an IMAX opening-weekend release in the U.S., which could blunt upside from that particular tentpole and offset some gains from other exclusives. Avengers Windowing

Institutional Investors Weigh In On IMAX

Institutional investors and hedge funds have recently modified their holdings of the stock. JPMorgan Chase & Co. increased its stake in shares of IMAX by 10.9% in the second quarter. JPMorgan Chase & Co. now owns 1,029,602 shares of the company’s stock worth $28,788,000 after buying an additional 101,048 shares during the last quarter. Principal Financial Group Inc. boosted its stake in IMAX by 67.8% during the 3rd quarter. Principal Financial Group Inc. now owns 70,927 shares of the company’s stock valued at $2,323,000 after acquiring an additional 28,667 shares during the last quarter. Zhang Financial LLC acquired a new position in IMAX during the 3rd quarter worth $903,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of IMAX in the 3rd quarter worth about $4,893,000. Finally, Thrivent Financial for Lutherans bought a new stake in shares of IMAX in the 3rd quarter worth about $3,272,000. Hedge funds and other institutional investors own 93.51% of the company’s stock.

IMAX Stock Performance

The business’s 50 day moving average price is $36.44 and its 200-day moving average price is $33.99. The firm has a market cap of $2.31 billion, a price-to-earnings ratio of 69.13, a price-to-earnings-growth ratio of 2.07 and a beta of 0.38.

IMAX (NYSE:IMAX) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.15. IMAX had a return on equity of 13.69% and a net margin of 8.50%.The business had revenue of $125.21 million during the quarter, compared to the consensus estimate of $120.30 million. During the same period last year, the firm earned $0.27 earnings per share. The company’s revenue for the quarter was up 35.1% compared to the same quarter last year. On average, analysts forecast that IMAX Corporation will post 0.91 earnings per share for the current fiscal year.

IMAX Company Profile

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.